REM0045392
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REM0045392, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants. [Phase 1]